Intensified neoadjuvant chemoradiotherapy (CRT) with capecitabine and irinotecan in patients with locally advanced rectal cancer (LARC): A phase I/II study.

被引：0
|
作者：
Klautke, G
Foitzik, T
Ludwig, K
Klar, EJM
Fietkau, R
机构：
[1] Univ Rostock, Rostock, Germany
[2] Klinikum Sudstadt, Rostock, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3693
引用
收藏
页码：292S / 292S
页数：1
相关论文
共 50 条
  • [1] Phase II Trial of Neoadjuvant Capecitabine (Cp) with Irinotecan (Ir) followed by Capecitabine-based Chemoradiotherapy (CRT) for Patients (pts) with Locally Advanced Rectal Cancer (LARC): A Hoosier Oncology Group Study
    Cardenes, H.
    Sanghani, S.
    Burns, M.
    Robb, B.
    Hinkle, D.
    Johnson, C.
    Yu, M.
    Currie, C.
    Loehrer, P.
    Chiorean, E.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S54 - S54
  • [2] Phase II study of neoadjuvant irinotecan, capecitabine, oxaliplatin (IXO) followed by chemoradiotherapy (CRT) using concurrent capecitabine for resectable locally advanced rectal cancer
    Jonker, Derek J.
    Maroun, Jean Alfred
    Auer, Rebecca Ann C.
    Yarom, Nirit
    Marginean, Celia
    Shabana, Weal
    Pantarotto, Jason R.
    Asmis, Timothy R.
    Boushey, Robin P.
    Goodwin, Rachel Anne
    Kendal, Wayne
    Tadros, Shaheer
    Grimard, Laval Jacques
    Moloo, Husein
    Friedlich, Martin
    Bohemier, Caryn
    Marginean, Horia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Phase II trial of neoadjuvant capecitabine (C) with irinotecan (I) followed by capecitabine-based chemoradiotherapy (CRT) for patients (pts) with locally advanced rectal cancer (LARC): HOG GI03-53
    Cardenes, H. R.
    Sanghani, S.
    Burns, M.
    Robb, M.
    Hinkle, D. T.
    Johnson, C. S.
    Yu, M.
    Currie, C. R.
    Loehrer, P. J.
    Chiorean, E. G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] A Phase I Study of Neoadjuvant Capecitabine, Oxaliplatin, and Irinotecan (XELOXIRI) in Patients with Locally Advanced Rectal Cancer
    Kudo, Toshihiro
    Takemasa, Ichiro
    Hata, Tsuyoshi
    Sakai, Daisuke
    Takahashi, Hidekazu
    Haraguchi, Naotsugu
    Nishimura, Junichi
    Hata, Taishi
    Matsuda, Chu
    Satoh, Taroh
    Mizushima, Tsunekazu
    Mori, Masaki
    Doki, Yuichiro
    [J]. ONCOLOGY, 2019, 97 (04) : 211 - 216
  • [5] A phase II study of neoadjuvant capecitabine, oxaliplatin, and irinotecan (XELOXIRI) in patients with locally advanced rectal cancer
    Matsuda, Chu
    Kudo, Toshihiro
    Morimoto, Yoshihiro
    Kagawa, Yoshinori
    Tei, Mitsuyoshi
    Ide, Yoshihito
    Miyoshi, Norikatsu
    Takahashi, Hidekazu
    Uemura, Mamoru
    Takemasa, Ichiro
    Satoh, Taroh
    Mizushima, Tsunekazu
    Murata, Kohei
    Doki, Yuichiro
    Eguchi, Hidetoshi
    [J]. ANNALS OF GASTROENTEROLOGICAL SURGERY, 2023, 7 (01): : 81 - 90
  • [6] Impact of age on efficacy of neoadjuvant chemoradiotherapy (CRT) in locally advanced rectal cancer (LARC)
    Calderillo, G.
    Herrera, M.
    Lopez, H.
    Diaz, C.
    Padilla, A.
    Ruiz-Garcia, E.
    Trejo, E.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 : 38 - 38
  • [7] Phase I study of trametinib with neoadjuvant chemoradiation (CRT) in patients with locally advanced rectal cancers (LARC).
    Wu, Christina Sing-Ying
    Williams, Terence Marques
    Wei, Lai
    Umar, Hamida
    Mikhail, Sameh
    Ciombor, Kristen Keon
    Chan, Emily
    Noonan, Anne M.
    Roychowdhury, Sameek
    El-Dika, Samer S.
    Krishna, Somashekar
    McCarthy, Sean T.
    Arnold, Mark
    Harzman, Alan
    Abdel-Misih, Sherif
    Cirocco, William
    Traugott, Amber
    Bekaii-Saab, Tanios S.
    Wuthrick, Evan John
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] A Phase I Study of Capecitabine, Irinotecan, Celecoxib, and Radiation as Neoadjuvant Therapy of Patients With Locally Advanced Rectal Cancer
    Malik, Imtiaz
    Hussein, Farabi
    Bush, David
    Alqaisi, Munther
    Bernal, Pedro
    Byrd, Janet
    Garberoglio, Carlos
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (03): : 242 - 245
  • [9] Phase II study of preoperative chemoradiation (CRT) with cetuximab, irinotecan and capecitabine in patients with locally advanced resectable rectal cancer
    Hong, Y. S.
    Kim, D. Y.
    Lee, K. S.
    Lim, S. B.
    Choi, H. S.
    Jeong, S. Y.
    Kim, J. H.
    Im, S. A.
    Kim, T. W.
    Jung, K. H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Concurrent radiotherapy with capecitabine and weekly irinotecan as neoadjuvant treatment for locally advanced rectal cancer: a phase I/II study
    Klautke, Gunther
    Feyerherd, Peter
    Ludwig, Kaja
    Foitzik, Thomas
    Klar, Ernst
    Fietkau, Rainer
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 80 - 80
12345